Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Accepted 2026-05-22 19:00:06 ET · period of report 2026-05-15 · accession 0001684273-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-22 19:00 | 2026-05-15 | MRVI | Dolan Christine | See Remarks | A - Grant | $1.79 | +5,006 | 425.3K | +1% | +$8,961 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-05-15 | A | A | 5,006 | $1.79 | 425,318 | D | — | — | (F1) The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 5,006 shares of Class A Common Stock was exempt pursuant to Rule 16b-3. |